The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
Peptide therapeutics: Targeting the undruggable space
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Protein Therapeutics: A Summary and Pharmacological Classification
Leader, B., Baca, Q. J., & Golan, D. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2399 · Cited by 2,161
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
Tse, C., Shoemaker, A. R., Adickes, J., Anderson, M. G., Chen, J., Jin, S., Johnson, E. F., Marsh, K. C., Mitten, M. J., Nimmer, P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5836 · Cited by 1,992
A Hot Spot of Binding Energy in a Hormone-Receptor Interface
Clackson, T., & Wells, J. A. (1995) · Science · doi:10.1126/science.7529940 · Cited by 1,983
Diagnosing the decline in pharmaceutical R&D efficiency
Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3681 · Cited by 1,981
The Future of Peptide‐based Drugs
Craik, D. J., Fairlie, D. P., Liras, S., & Price, D. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12055 · Cited by 1,979
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
Wells, J. A., & McClendon, C. L. (2007) · Nature · doi:10.1038/nature06526 · Cited by 1,960
Cell-free translation reconstituted with purified components
Shimizu, Y., Inoue, A., Tomari, Y., Suzuki, T., Yokogawa, T., Nishikawa, K., & Ueda, T. (2001) · Nature Biotechnology · doi:10.1038/90802 · Cited by 1,940
Synthetic therapeutic peptides: science and market
Vlieghe, P., Lisowski, V., Martinez, J., & Khrestchatisky, M. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2009.10.009 · Cited by 1,476
The exploration of macrocycles for drug discovery — an underexploited structural class
Driggers, E. M., Hale, S. P., Lee, J., & Terrett, N. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2590 · Cited by 1,370
Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix
Walensky, L. D., Kung, A. L., Escher, I., Malia, T. J., Barbuto, S., Wright, R. D., Wagner, G., Verdine, G. L., & Korsmeyer, S. J. (2004) · Science · doi:10.1126/science.1099191 · Cited by 1,349
Grubbs, R. H. (2004) · Tetrahedron · doi:10.1016/j.tet.2004.05.124 · Cited by 1,205
RNA-peptide fusions for the in vitro selection of peptides and proteins
Roberts, R. W., & Szostak, J. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12297 · Cited by 1,105
Contemporary strategies for peptide macrocyclization
White, C. J., & Yudin, A. K. (2011) · Nature Chemistry · doi:10.1038/nchem.1062 · Cited by 1,088
Schafmeister, C. E., Po, J., & Verdine, G. L. (2000) · Journal of the American Chemical Society · doi:10.1021/ja000563a · Cited by 1,037
Cell-penetrating peptides: classes, origin, and current landscape
Milletti, F. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.002 · Cited by 813
Direct inhibition of the NOTCH transcription factor complex
Moellering, R. E., Cornejo, M., Davis, T. N., Bianco, C. D., Aster, J. C., Blacklow, S. C., Kung, A. L., Gilliland, D. G., Verdine, G. L., & Bradner, J. E. (2009) · Nature · doi:10.1038/nature08543 · Cited by 752
Future directions for peptide therapeutics development
Kaspar, A. A., & Reichert, J. M. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.05.011 · Cited by 750
Phage-encoded combinatorial chemical libraries based on bicyclic peptides
Heinis, C., Rutherford, T., Freund, S., & Winter, G. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.184 · Cited by 743
Chang, Y. S., Graves, B., Guerlavais, V., Tovar, C., Packman, K., To, K.-H., Olson, K. A., Kesavan, K., Gangurde, P., Mukherjee, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303002110 · Cited by 660
Gentilucci, L., De Marco, R., & Cerisoli, L. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210793292555 · Cited by 586
N-Methylation of Peptides: A New Perspective in Medicinal Chemistry
Chatterjee, J., Gilon, C., Hoffman, A., & Kessler, H. (2008) · Accounts of Chemical Research · doi:10.1021/ar8000603 · Cited by 577
Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties?
Giordanetto, F., & Kihlberg, J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm400887j · Cited by 563
Peptidomimetic Antibiotics Target Outer-Membrane Biogenesis in Pseudomonas aeruginosa
Srinivas, N., Jetter, P., Ueberbacher, B. J., Werneburg, M., Zerbe, K., Steinmann, J., Van der Meijden, B., Bernardini, F., Lederer, A., Dias, R. L. A., et al. (2010) · Science · doi:10.1126/science.1182749 · Cited by 554
DNA-Templated Organic Synthesis and Selection of a Library of Macrocycles
Gartner, Z. J., Tse, B. N., Grubina, R., Doyon, J. B., Snyder, T. M., & Liu, D. R. (2004) · Science · doi:10.1126/science.1102629 · Cited by 503
Rezai, T., Yu, B., Millhauser, G. L., Jacobson, M. P., & Lokey, R. S. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0563455 · Cited by 490
A Perfluoroaryl-Cysteine S N Ar Chemistry Approach to Unprotected Peptide Stapling
Spokoyny, A. M., Zou, Y., Ling, J. J., Yu, H., Lin, Y.-S., & Pentelute, B. L. (2013) · Journal of the American Chemical Society · doi:10.1021/ja400119t · Cited by 474
Flexizymes for genetic code reprogramming
Goto, Y., Katoh, T., & Suga, H. (2011) · Nature Protocols · doi:10.1038/nprot.2011.331 · Cited by 472
A highly flexible tRNA acylation method for non-natural polypeptide synthesis
Murakami, H., Ohta, A., Ashigai, H., & Suga, H. (2006) · Nature Methods · doi:10.1038/nmeth877 · Cited by 468
Macrocycles In New Drug Discovery
Mallinson, J., & Collins, I. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.93 · Cited by 468
Stapled Peptides for Intracellular Drug Targets
Verdine, G. L., & Hilinski, G. J. (2012) · Methods in Enzymology · doi:10.1016/b978-0-12-396962-0.00001-x · Cited by 433
Butelase 1 is an Asx-specific ligase enabling peptide macrocyclization and synthesis
Nguyen, G. K. T., Wang, S., Qiu, Y., Hemu, X., Lian, Y., & Tam, J. P. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1586 · Cited by 431
Constraining Cyclic Peptides To Mimic Protein Structure Motifs
Hill, T. A., Shepherd, N. E., Diness, F., & Fairlie, D. P. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201401058 · Cited by 418
Rezai, T., Bock, J. E., Zhou, M. V., Kalyanaraman, C., Lokey, R. S., & Jacobson, M. P. (2006) · Journal of the American Chemical Society · doi:10.1021/ja063076p · Cited by 416
Targeting protein–protein interactions as an anticancer strategy
Ivanov, A. A., Khuri, F. R., & Fu, H. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.04.007 · Cited by 401
Villar, E. A., Beglov, D., Chennamadhavuni, S., Porco, J. A., Kozakov, D., Vajda, S., & Whitty, A. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1584 · Cited by 400
Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX
Pazgier, M., Liu, M., Zou, G., Yuan, W., Li, C., Li, C., Li, J., Monbo, J., Zella, D., Tarasov, S. G., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900947106 · Cited by 391
On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds
White, T. R., Renzelman, C. M., Rand, A. C., Rezai, T., McEwen, C. M., Gelev, V. M., Turner, R. A., Linington, R. G., Leung, S. S. F., Kalgutkar, A. S., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.664 · Cited by 386
Therapeutic peptides: technological advances driving peptides into development
Sato, A. K., Viswanathan, M., Kent, R. B., & Wood, C. R. (2006) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2006.10.002 · Cited by 362
Peptide conformations. Part 31. The conformation of cyclosporin a in the crystal and in solution
Loosli, H., Kessler, H., Oschkinat, H., Weber, H., Petcher, T. J., & Widmer, A. (1985) · Helvetica Chimica Acta · doi:10.1002/hlca.19850680319 · Cited by 347
Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic
Bird, G. H., Madani, N., Perry, A. F., Princiotto, A. M., Supko, J. G., He, X., Gavathiotis, E., Sodroski, J. G., & Walensky, L. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002713107 · Cited by 347
Dimitrov, D. S. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-921-1_1 · Cited by 347
Yamagishi, Y., Shoji, I., Miyagawa, S., Kawakami, T., Katoh, T., Goto, Y., & Suga, H. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.09.013 · Cited by 346
Targeted disruption of the EZH2–EED complex inhibits EZH2-dependent cancer
Kim, W., Bird, G. H., Neff, T., Guo, G., Kerenyi, M. A., Walensky, L. D., & Orkin, S. H. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1331 · Cited by 338
Hoveyda, A. H., Gillingham, D. G., Van Veldhuizen, J. J., Kataoka, O., Garber, S. B., Kingsbury, J. S., & Harrity, J. P. A. (2004) · Organic & Biomolecular Chemistry · doi:10.1039/b311496c · Cited by 330
Single Turn Peptide Alpha Helices with Exceptional Stability in Water
Shepherd, N. E., Hoang, H. N., Abbenante, G., & Fairlie, D. P. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0456003 · Cited by 326
β-Hairpin Peptidomimetics: Design, Structures and Biological Activities
Robinson, J. A. (2008) · Accounts of Chemical Research · doi:10.1021/ar700259k · Cited by 321
Oncogenic protein interfaces: small molecules, big challenges
Nero, T. L., Morton, C. J., Holien, J. K., Wielens, J., & Parker, M. W. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3690 · Cited by 312
Predicting druggable binding sites at the protein–protein interface
Fuller, J. C., Burgoyne, N. J., & Jackson, R. M. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2008.10.009 · Cited by 310
Albericio, F., & Kruger, H. G. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.94 · Cited by 307
An orthosteric inhibitor of the Ras-Sos interaction
Patgiri, A., Yadav, K. K., Arora, P. S., & Bar-Sagi, D. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.612 · Cited by 295
Timmerman, P., Beld, J., Puijk, W. C., & Meloen, R. H. (2005) · ChemBioChem · doi:10.1002/cbic.200400374 · Cited by 295
Zhao, Y., Yu, S., Sun, W., Liu, L., Lu, J., McEachern, D., Shargary, S., Bernard, D., Li, X., Zhao, T., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4005708 · Cited by 290
Contemporary strategies for the stabilization of peptides in the α-helical conformation
Henchey, L. K., Jochim, A. L., & Arora, P. S. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.08.019 · Cited by 288
Smith, M. C., & Gestwicki, J. E. (2012) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2012.10 · Cited by 286
Reprogramming the Translation Initiation for the Synthesis of Physiologically Stable Cyclic Peptides
Goto, Y., Ohta, A., Sako, Y., Yamagishi, Y., Murakami, H., & Suga, H. (2008) · ACS Chemical Biology · doi:10.1021/cb700233t · Cited by 275
Development of α-Helical Calpain Probes by Mimicking a Natural Protein–Protein Interaction
Jo, H., Meinhardt, N., Wu, Y., Kulkarni, S., Hu, X., Low, K. E., Davies, P. L., DeGrado, W. F., & Greenbaum, D. C. (2012) · Journal of the American Chemical Society · doi:10.1021/ja307599z · Cited by 261
Exploring β-Sheet Structure and Interactions with Chemical Model Systems
Nowick, J. S. (2008) · Accounts of Chemical Research · doi:10.1021/ar800064f · Cited by 252
Kawamoto, S. A., Coleska, A., Ran, X., Yi, H., Yang, C.-Y., & Wang, S. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201125d · Cited by 249
Crystal structure of human calcineurin complexed with cyclosporin A and human cyclophilin
Jin, L., & Harrison, S. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212504399 · Cited by 244
In Vitro Selection of Highly Modified Cyclic Peptides That Act as Tight Binding Inhibitors
Guillen Schlippe, Y. V., Hartman, M. C. T., Josephson, K., & Szostak, J. W. (2012) · Journal of the American Chemical Society · doi:10.1021/ja301017y · Cited by 239
Macrocyclization of Linear Peptides Enabled by Amphoteric Molecules
Hili, R., Rai, V., & Yudin, A. K. (2010) · Journal of the American Chemical Society · doi:10.1021/ja910544p · Cited by 235
Ribosomal Synthesis of Unnatural Peptides
Josephson, K., Hartman, M. C. T., & Szostak, J. W. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0515809 · Cited by 233
In Vivo Activation of the p53 Tumor Suppressor Pathway by an Engineered Cyclotide
Ji, Y., Majumder, S., Millard, M., Borra, R., Bi, T., Elnagar, A. Y., Neamati, N., Shekhtman, A., & Camarero, J. A. (2013) · Journal of the American Chemical Society · doi:10.1021/ja405108p · Cited by 233
A Highly Stable Short α-Helix Constrained by a Main-Chain Hydrogen-Bond Surrogate
Chapman, R. N., Dimartino, G., & Arora, P. S. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0466659 · Cited by 228
The Supramolecular Chemistry of β-Sheets
Cheng, P.-N., Pham, J. D., & Nowick, J. S. (2013) · Journal of the American Chemical Society · doi:10.1021/ja3088407 · Cited by 228
Druggable protein–protein interactions – from hot spots to hot segments
London, N., Raveh, B., & Schueler-Furman, O. (2013) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2013.10.011 · Cited by 223
Bock, J. E., Gavenonis, J., & Kritzer, J. A. (2013) · ACS Chemical Biology · doi:10.1021/cb300515u · Cited by 221
Towards understanding cell penetration by stapled peptides
Chu, Q., Moellering, R. E., Hilinski, G. J., Kim, Y.-W., Grossmann, T. N., Yeh, J. T.-H., & Verdine, G. L. (2015) · MedChemComm · doi:10.1039/c4md00131a · Cited by 219
A Cell-penetrating Helical Peptide as a Potential HIV-1 Inhibitor
Zhang, H., Zhao, Q., Bhattacharya, S., Waheed, A. A., Tong, X., Hong, A., Heck, S., Curreli, F., Goger, M., Cowburn, D., et al. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.02.066 · Cited by 215
Functionalised staple linkages for modulating the cellular activity of stapled peptides
Lau, Y. H., de Andrade, P., Quah, S.-T., Rossmann, M., Laraia, L., Sköld, N., Sum, T. J., Rowling, P. J. E., Joseph, T. L., Verma, C., et al. (2014) · Chem. Sci. · doi:10.1039/c4sc00045e · Cited by 214
mRNA display: from basic principles to macrocycle drug discovery
Josephson, K., Ricardo, A., & Szostak, J. W. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2013.10.011 · Cited by 210
Rationalizing the chemical space of protein–protein interaction inhibitors
Sperandio, O., Reynès, C. H., Camproux, A.-C., & Villoutreix, B. O. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2009.11.007 · Cited by 202
Comprehensive analysis of loops at protein-protein interfaces for macrocycle design
Gavenonis, J., Sheneman, B. A., Siegert, T. R., Eshelman, M. R., & Kritzer, J. A. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1580 · Cited by 198
Systematic Analysis of Helical Protein Interfaces Reveals Targets for Synthetic Inhibitors
Jochim, A. L., & Arora, P. S. (2010) · ACS Chemical Biology · doi:10.1021/cb1001747 · Cited by 191
Cantel, S., Le Chevalier Isaad, A., Scrima, M., Levy, J. J., DiMarchi, R. D., Rovero, P., Halperin, J. A., D’Ursi, A. M., Papini, A. M., & Chorev, M. (2008) · The Journal of Organic Chemistry · doi:10.1021/jo800142s · Cited by 190
Intestinal Permeability of Cyclic Peptides: Common Key Backbone Motifs Identified
Beck, J. G., Chatterjee, J., Laufer, B., Kiran, M. U., Frank, A. O., Neubauer, S., Ovadia, O., Greenberg, S., Gilon, C., Hoffman, A., et al. (2012) · Journal of the American Chemical Society · doi:10.1021/ja303200d · Cited by 187
Form and Function in Cyclic Peptide Natural Products: A Pharmacokinetic Perspective
Bockus, A. T., McEwen, C. M., & Lokey, R. S. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611313070005 · Cited by 187
An Expanded Set of Amino Acid Analogs for the Ribosomal Translation of Unnatural Peptides
Hartman, M. C. T., Josephson, K., Lin, C.-W., & Szostak, J. W. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000972 · Cited by 183
Bicyclic Peptide Inhibitor Reveals Large Contact Interface with a Protease Target
Angelini, A., Cendron, L., Chen, S., Touati, J., Winter, G., Zanotti, G., & Heinis, C. (2012) · ACS Chemical Biology · doi:10.1021/cb200478t · Cited by 182
Fasan, R., Dias, R. L. A., Moehle, K., Zerbe, O., Vrijbloed, J. W., Obrecht, D., & Robinson, J. A. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200353242 · Cited by 180
Expanding the Number of ‘Druggable’ Targets: Non‐Enzymes and Protein–Protein Interactions
Makley, L. N., & Gestwicki, J. E. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12066 · Cited by 176
Guharoy, M., & Chakrabarti, P. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm274 · Cited by 176
Morimoto, J., Hayashi, Y., & Suga, H. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201108118 · Cited by 175
Comparative α‐Helicity of Cyclic Pentapeptides in Water
de Araujo, A. D., Hoang, H. N., Kok, W. M., Diness, F., Gupta, P., Hill, T. A., Driver, R. W., Price, D. A., Liras, S., & Fairlie, D. P. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201310245 · Cited by 174
Identification and Characterization of a New Family of Cell-penetrating Peptides
Cascales, L., Henriques, S. T., Kerr, M. C., Huang, Y.-H., Sweet, M. J., Daly, N. L., & Craik, D. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.264424 · Cited by 172
Cabezas, E., & Satterthwait, A. C. (1999) · Journal of the American Chemical Society · doi:10.1021/ja983212t · Cited by 168
London, N., Raveh, B., Movshovitz‐Attias, D., & Schueler‐Furman, O. (2010) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.22785 · Cited by 164
Cyclotides as templates in drug design
Henriques, S. T., & Craik, D. J. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.10.007 · Cited by 151
Hipolito, C. J., & Suga, H. (2012) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2012.02.014 · Cited by 147
Hot-spot mimicry of a cytokine receptor by a small molecule
Thanos, C. D., DeLano, W. L., & Wells, J. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607058103 · Cited by 144
Diverse backbone-cyclized peptides via codon reprogramming
Kawakami, T., Ohta, A., Ohuchi, M., Ashigai, H., Murakami, H., & Suga, H. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.259 · Cited by 142
The design, structures and therapeutic potential of protein epitope mimetics
Robinson, J. A., DeMarco, S. T., Gombert, F. O., Moehle, K., & Obrecht, D. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.07.008 · Cited by 140
Peptide Ligands Stabilized by Small Molecules
Chen, S., Bertoldo, D., Angelini, A., Pojer, F., & Heinis, C. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201309459 · Cited by 137
Henchey, L. K., Kushal, S., Dubey, R., Chapman, R. N., Olenyuk, B. Z., & Arora, P. S. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9082864 · Cited by 136
Hayashi, Y., Morimoto, J., & Suga, H. (2012) · ACS Chemical Biology · doi:10.1021/cb200388k · Cited by 136
Disulfide-rich macrocyclic peptides as templates in drug design
Northfield, S. E., Wang, C. K. L., Schroeder, C. I., Durek, T., Kan, M., Swedberg, J. E., & Craik, D. J. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.03.011 · Cited by 135
Peptides And Peptide Conjugates: Therapeutics On The Upward Path
Ahrens, V. M., Bellmann‐Sickert, K., & Beck‐Sickinger, A. G. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.76 · Cited by 135
Assessment of helical interfaces in protein–protein interactions
Jochim, A. L., & Arora, P. S. (2009) · Molecular BioSystems · doi:10.1039/b903202a · Cited by 134
Buchwald, P. (2010) · IUBMB Life · doi:10.1002/iub.383 · Cited by 133
Human protein–protein interaction networks and the value for drug discovery
Ruffner, H., Bauer, A., & Bouwmeester, T. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.07.011 · Cited by 133
Reinvestigation of the Conformation of Cyclosporin A in Chloroform
Kessler, H., Köck, M., Wein, T., & Gehrke, M. (1990) · Helvetica Chimica Acta · doi:10.1002/hlca.19900730703 · Cited by 131
Intrinsically Cell-Permeable Miniature Proteins Based on a Minimal Cationic PPII Motif
Daniels, D. S., & Schepartz, A. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0772445 · Cited by 130
Lian, W., Upadhyaya, P., Rhodes, C. A., Liu, Y., & Pei, D. (2013) · Journal of the American Chemical Society · doi:10.1021/ja405106u · Cited by 129
Protein Prosthesis: A Semisynthetic Enzyme with a β-Peptide Reverse Turn
Arnold, U., Hinderaker, M. P., Nilsson, B. L., Huck, B. R., Gellman, S. H., & Raines, R. T. (2002) · Journal of the American Chemical Society · doi:10.1021/ja026114n · Cited by 128
Reynès, C., Host, H., Camproux, A., Laconde, G., Leroux, F., Mazars, A., Deprez, B. P., Fåhræus, R., Villoutreix, B. O., & Spérandio, O. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000695 · Cited by 124
α-Helix mimetics: Outwards and upwards
Jayatunga, M. K. P., Thompson, S., & Hamilton, A. D. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.12.003 · Cited by 122
Joo, S. H., Xiao, Q., Ling, Y. L., Gopishetty, B., & Pei, D. (2006) · Journal of the American Chemical Society · doi:10.1021/ja063722k · Cited by 120
Cyclotides as a basis for drug design
Craik, D. J., Swedberg, J. E., Mylne, J. S., & Čemažar, M. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.661554 · Cited by 115
Cellular uptake of cyclotide MCoTI-I follows multiple endocytic pathways
Contreras, J., Elnagar, A. Y., Hamm‐Alvarez, S. F., & Camarero, J. A. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.030 · Cited by 112
N-Methylated Cyclic Pentaalanine Peptides as Template Structures
Chatterjee, J., Mierke, D. F., & Kessler, H. (2006) · Journal of the American Chemical Society · doi:10.1021/ja063123d · Cited by 111
Chorev, M., Roubini, E., McKee, R. L., Gibbons, S. W., Goldman, M. E., Caulfield, M. P., & Rosenblatt, M. (1991) · Biochemistry · doi:10.1021/bi00238a022 · Cited by 107
The cyclic cystine knot miniprotein MCoTI-II is internalized into cells by macropinocytosis
Greenwood, K. P., Daly, N. L., Brown, D. L., Stow, J. L., & Craik, D. J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.06.016 · Cited by 105
Protein domain mimetics as in vivo modulators of hypoxia-inducible factor signaling
Kushal, S., Lao, B. B., Henchey, L. K., Dubey, R., Mesallati, H., Traaseth, N. J., Olenyuk, B. Z., & Arora, P. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312473110 · Cited by 103
Flexizymes: Their Evolutionary History and the Origin of Catalytic Function
Morimoto, J., Hayashi, Y., Iwasaki, K., & Suga, H. (2011) · Accounts of Chemical Research · doi:10.1021/ar2000953 · Cited by 103
Bicyclic Peptide Ligands Pulled out of Cysteine-Rich Peptide Libraries
Chen, S., Rebollo, I. R., Buth, S. A., Morales‐Sanfrutos, J., Touati, J., Leiman, P. G., & Heinis, C. (2013) · Journal of the American Chemical Society · doi:10.1021/ja400461h · Cited by 102
Distinct BimBH3 (BimSAHB) Stapled Peptides for Structural and Cellular Studies
Bird, G. H., Gavathiotis, E., LaBelle, J. L., Katz, S. G., & Walensky, L. D. (2013) · ACS Chemical Biology · doi:10.1021/cb4003305 · Cited by 101
Evaluating β-turn mimics as β-sheet folding nucleators
Fuller, A. A., Du, D., Liu, F., Davoren, J. E., Bhabha, G., Kroon, G. J. A., Case, D. A., Dyson, H. J., Powers, E. T., Wipf, P., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813012106 · Cited by 99
Bird, G. H., Crannell, W. C., & Walensky, L. D. (2011) · Current Protocols in Chemical Biology · doi:10.1002/9780470559277.ch110042 · Cited by 90
Miniature Protein Inhibitors of the p53–hDM2 Interaction
Kritzer, J. A., Zutshi, R., Cheah, M. T., Ran, F. A., Webman, R. B., Wongjirad, T. M., & Schepartz, A. (2006) · ChemBioChem · doi:10.1002/cbic.200500324 · Cited by 90
Convergent diversity-oriented side-chain macrocyclization scan for unprotected polypeptides
Zou, Y., Spokoyny, A. M., Zhang, C., Simon, M. D., Yu, H., Lin, Y., & Pentelute, B. L. (2013) · Organic & Biomolecular Chemistry · doi:10.1039/c3ob42168f · Cited by 85
Lead discovery and optimization strategies for peptide macrocycles
Bhat, A., Roberts, L. R., & Dwyer, J. J. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.07.083 · Cited by 85
Apamin as a Template for Structure‐Based Rational Design of Potent Peptide Activators of p53
Li, C., Pazgier, M., Liu, M., Lu, W., & Lu, W. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200904550 · Cited by 82
Turning a Scorpion Toxin into an Antitumor Miniprotein
Li, C., Liu, M., Monbo, J., Zou, G., Li, C., Yuan, W., Zella, D., Lu, W., & Lu, W. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8042036 · Cited by 80
Conformation of cyclosporin A in polar solvents
Ko, S. Y., & Dalvit, C. (1992) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1992.tb00314.x · Cited by 74
Discovery of a new small-molecule inhibitor of p53–MDM2 interaction using a yeast-based approach
Leão, M., Pereira, C., Bisio, A., Ciribilli, Y., Paiva, A. M. O., Machado, N., Palmeira, A., Fernandes, M. X., Sousa, E., Pinto, M. M. M., et al. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.01.032 · Cited by 71
All-hydrocarbon stapled peptides as Synthetic Cell-Accessible Mini-Proteins
Verdine, G. L., & Hilinski, G. J. (2012) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2012.01.004 · Cited by 70
Kubowicz, P., Żelaszczyk, D., & Pękala, E. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990118 · Cited by 69
Chen, S., Gfeller, D., Buth, S. A., Michielin, O. A., Leiman, P. G., & Heinis, C. (2013) · ChemBioChem · doi:10.1002/cbic.201300228 · Cited by 68
Improvement of drug-like properties of peptides: the somatostatin paradigm
Ovadia, O., Greenberg, S., Laufer, B., Gilon, C., Hoffman, A., & Kessler, H. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2010.493935 · Cited by 65
Methods for the synthesis of macrocycle libraries for drug discovery
Terrett, N. K. (2010) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2010.06.002 · Cited by 61
Template-constrained macrocyclic peptides prepared from native, unprotected precursors
Lawson, K. V., Rose, T. E., & Harran, P. G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311706110 · Cited by 60
β-Hairpin protein epitope mimetic technology in drug discovery
Obrecht, D., Chevalier, É., Moehle, K., & Robinson, J. A. (2011) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2011.07.006 · Cited by 59
Ask the Experts: Past, Present and Future of the Rule of Five
Baell, J. B., Congreve, M., Leeson, P. D., et al. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.61 · Cited by 58
HENRY, C. M. (2005) · Chemical & Engineering News · doi:10.1021/cen-v083n025.p017 · Cited by 55
Bicyclization and Tethering to Albumin Yields Long-Acting Peptide Antagonists
Angelini, A., Morales‐Sanfrutos, J., Diderich, P., Chen, S., & Heinis, C. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301276e · Cited by 55
Miller, M. J., Foy, K. C., & Kaumaya, P. T. P. (2013) · PubMed · Cited by 54
WATCHING PEPTIDE DRUGS GROW UP
(2005) · Chemical & Engineering News · doi:10.1021/cen-v083n011.p017 · Cited by 54
Tomlinson, I. M. (2004) · Nature Biotechnology · doi:10.1038/nbt0504-521 · Cited by 51
Kaul, R., Deechongkit, S., & Kelly, J. W. (2002) · Journal of the American Chemical Society · doi:10.1021/ja020675x · Cited by 48
A New i, i + 3 Peptide Stapling System for α‐Helix Stabilization
Shim, S. Y., Kim, Y., & Verdine, G. L. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12231 · Cited by 45
End-capped α-helices as modulators of protein function
Mahon, A. B., & Arora, P. S. (2012) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2011.07.008 · Cited by 44
Efficient parallel synthesis of macrocyclic peptidomimetics
Marsault, É., Hoveyda, H. R., Gagnon, R., Peterson, M. L., Vézina, M., Saint‐Louis, C. J., Landry, A., Pinault, J.-F., Ouellet, L., Beauchemin, S., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.06.085 · Cited by 35
Inhibition of Nutlin-Resistant HDM2 Mutants by Stapled Peptides
Wei, S. J., Joseph, T. L., Chee, S. M. Q., Li, L., Yurlova, L., Zolghadr, K., Brown, C. J., Lane, D. P., Verma, C. S., & Ghadessy, F. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081068 · Cited by 27
Sawyer, T. K. (2008) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00744.x · Cited by 17
Verdine, G. L. (2010) · Wiley eBooks · doi:10.1002/9780470593042.ch1 · Cited by 15
Cited by
Targeting apoptosis in cancer therapy
Carneiro, B. A., & El-Deiry, W. S. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0341-y · Cited by 2,542
Trends in peptide drug discovery
Muttenthaler, M., King, G. F., Adams, D. J., & Alewood, P. F. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00135-8 · Cited by 1,964
Antimicrobial host defence peptides: functions and clinical potential
Mookherjee, N., Anderson, M. A., Haagsman, H. P., & Davidson, D. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0058-8 · Cited by 1,502
Use of molecular docking computational tools in drug discovery
(2021) · Progress in Medicinal Chemistry · doi:10.1016/bs.pmch.2021.01.004 · Cited by 621
Lundquist, P., & Artursson, P. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.07.007 · Cited by 483
Metadata
- Authors
- Tsomaia, N.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 94
- Pages
- 459-470
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W2018687970
- Cited by
- 348
- References
- 149
- FWCI
- 11.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.